AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 194 filers reported holding AXSOME THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.52 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $44,134,626 | +6.9% | 631,487 | +9.9% | 0.71% | +20.7% |
| Q2 2023 | $41,273,725 | +51.6% | 574,363 | +30.1% | 0.59% | +49.1% |
| Q1 2023 | $27,222,468 | -19.2% | 441,350 | +1.1% | 0.40% | -11.6% |
| Q4 2022 | $33,679,431 | +52.0% | 436,658 | -12.1% | 0.45% | +40.6% |
| Q3 2022 | $22,155,000 | -29.2% | 496,524 | -39.2% | 0.32% | -28.1% |
| Q2 2022 | $31,297,000 | +5.1% | 817,141 | +13.6% | 0.44% | +27.7% |
| Q1 2022 | $29,779,000 | +20.9% | 719,482 | +10.4% | 0.35% | +36.2% |
| Q4 2021 | $24,630,000 | -0.8% | 651,937 | -13.4% | 0.25% | +0.8% |
| Q3 2021 | $24,817,000 | +4.5% | 752,945 | +113.9% | 0.25% | +8.6% |
| Q2 2021 | $23,747,000 | – | 352,021 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,132,645 | $37,332,000 | 32.86% |
| MORGAN JESS S & CO INC | 113,430 | $3,739,000 | 2.47% |
| Fairmount Funds Management LLC | 187,598 | $6,183,000 | 2.25% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 1,423,653 | $46,924,000 | 1.43% |
| WMS Partners, LLC | 250,000 | $8,240,000 | 1.21% |
| Beck Bode, LLC | 102,127 | $3,366,000 | 0.94% |
| RTW INVESTMENTS, LP | 1,616,497 | $53,280,000 | 0.80% |
| MPM BioImpact LLC | 110,155 | $3,631,000 | 0.56% |
| Endurant Capital Management LP | 52,048 | $1,716,000 | 0.39% |
| Bellevue Group AG | 752,945 | $24,817,000 | 0.25% |